Biotechnology company Sanobiotec, registered last year and implementing an oncologic research project in cooperation with Lithuania's National Cancer Institute, is setting up its activity at Vilnius City Innovation Industrial Park and plans to invest up to 8 million euros and create 80 new jobs, the Verslo Zinios business daily writes.
© DELFI / Kiril Čachovskij

The company will set up in an area of 55 acres and plans to build a research and experimental development center and administrative premises.

The construction is set to start in November, and the company plans to start its activities in 2021.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Prime Minister vows to balance 2020 budget after tax proposals rejected

Lithuanian Prime Minister Saulius Skvernelis says his Cabinet's updated 2020 state budget plan...

Skvernelis: risks involved in Belaruskali's investments in Klaipeda are conrolled

Lithuanian Prime Minister Saulius Skvernelis says his government controls the potential risks...

Japan plans to involve in Baltic synchronization project

The Baltic states, which are gearing up for the synchronization of their power networks with those...

Lithuanian researchers developed new technology for precision grinding

A team of researchers at Kaunas University of Technology (KTU) has developed a novel approach to...

Real estate tax expansion amendments returned to government

The Seimas of Lithuania lacked several votes on Tuesday to accept a proposal to expand the real...